NovaBridge Biosciences (NBP) Inventory (2021 - 2023)

NovaBridge Biosciences (NBP) has reported Inventory for 3 consecutive years, with $718742.3 the latest figure, recorded in Q4 2023.

• In Q4 2023, Inventory fell 84.49% year-over-year to $718742.3; the TTM figure through Dec 2023 stood at $718742.3 (down 84.49% YoY), while the FY2023 annual figure was $729000.0, down 84.75% from the prior year.
• Inventory eased to $718742.3 in Q4 2023 per NBP's latest filing, from $4.6 million in the prior quarter.
• Across five years, Inventory topped out at $4.3 billion in Q4 2021 and bottomed at $718742.3 in Q4 2023.
• Historically, Inventory has averaged $1.1 billion across 3 years, with a median of $7.6 million in 2022.
• Annual changes were most pronounced in 2022 — Inventory slumped 99.89% — and 2023, when it sank 84.49%.
• NovaBridge Biosciences' Inventory stood at $4.3 billion in 2021, then plunged by 99.89% to $4.6 million in 2022, then tumbled by 84.49% to $718742.3 in 2023.
• Business Quant data shows NBP's Inventory at $718742.3 in Q4 2023, $4.6 million in Q4 2022, and $10.5 million in Q2 2022.